A jury upheld the validity of Merck patents in a dispute with Gilead Sciences, which could be forced to hand over a portion of the billions of dollars it has made on hepatitis C drugs.
A jury upheld the validity of Merck patents in a dispute with Gilead Sciences, which could be forced to hand over a portion of the billions of dollars it has made on hepatitis C drugs.